APO Research
Talk to an analyst

APO RESEARCH · REPORT

RGD Peptide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global RGD Peptide Market Outlook and Growth Opportunities 2026

30 December 2025208 pages

Choose your research edition.

Industry ResearchRGD Peptide Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal RGD Peptide Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal RGD Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RGD Peptide Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal RGD Peptide Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global RGD Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the RGD Peptide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the RGD Peptide market include Wuhan Tanda Biotechnology, XIAN RUIXI, QYAOBIO, TGpeptide, Merck KGaA, Allpeptide, TargetMol Chemicals, Santa Cruz Animal Health and PEPTIDE INSTITUTE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global RGD Peptide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RGD Peptide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RGD Peptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RGD Peptide market size, projected growth trends, production technologies, key applications, and end-use industries.

RGD Peptide Segment by Company

Wuhan Tanda Biotechnology

XIAN RUIXI

QYAOBIO

TGpeptide

Merck KGaA

Allpeptide

TargetMol Chemicals

Santa Cruz Animal Health

PEPTIDE INSTITUTE

Novatein Biosciences

Enzo

Cell Guidance Systems

CD Bioparticles

Bio-Techne

BICO(Advanced BioMatrix)

ApexBio Technology

AnaSpec

Abbiotec

RGD Peptide Segment by Type

RGD Cyclic Peptide

Linear RGD Peptide

RGD Peptide Segment by Application

Pharmaceuticals

Scientific Research

RGD Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global RGD Peptide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions RGD Peptide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify RGD Peptide significant trends, drivers, influence factors in global and regions.

6. To analyze RGD Peptide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RGD Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RGD Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RGD Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the RGD Peptide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RGD Peptide industry.

Chapter 3: Detailed analysis of RGD Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of RGD Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of RGD Peptide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. RGD Peptide Industry Trends Table 2. RGD Peptide Industry Drivers Table 3. RGD Peptide Industry Opportunities and Challenges Table 4. RGD Peptide Industry Restraints Table 5. Global RGD Peptide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global RGD Peptide Revenue Share by Company (2021-2026) Table 7. Global RGD Peptide Sales Volume by Company (L) & (2021-2026) Table 8. Global RGD Peptide Sales Volume Share by Company (2021-2026) Table 9. Global RGD Peptide Average Price (US$/mL) of Company (2021-2026) Table 10. Global RGD Peptide Company Ranking, (2024-2026) & (USD Million) Table 11. Global RGD Peptide Key Company Manufacturing Base & Headquarters Table 12. Global RGD Peptide Company, Product Type & Application Table 13. Global RGD Peptide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global RGD Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of RGD Cyclic Peptide Table 18. Significant Companies of Linear RGD Peptide Table 19. Global RGD Peptide Sales Volume by Type 2021 VS 2025 VS 2032 (L) Table 20. Global RGD Peptide Sales Volume by Type (2021-2026) & (L) Table 21. Global RGD Peptide Sales Volume by Type (2027-2032) & (L) Table 22. Global RGD Peptide Sales Volume Share by Type (2021-2026) Table 23. Global RGD Peptide Sales Volume Share by Type (2027-2032) Table 24. Global RGD Peptide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global RGD Peptide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global RGD Peptide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global RGD Peptide Sales Value Share by Type (2021-2026) Table 28. Global RGD Peptide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceuticals Table 30. Significant Companies of Scientific Research Table 31. Global RGD Peptide Sales Volume by Application 2021 VS 2025 VS 2032 (L) Table 32. Global RGD Peptide Sales Volume by Application (2021-2026) & (L) Table 33. Global RGD Peptide Sales Volume by Application (2027-2032) & (L) Table 34. Global RGD Peptide Sales Volume Share by Application (2021-2026) Table 35. Global RGD Peptide Sales Volume Share by Application (2027-2032) Table 36. Global RGD Peptide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global RGD Peptide Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global RGD Peptide Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global RGD Peptide Sales Value Share by Application (2021-2026) Table 40. Global RGD Peptide Sales Value Share by Application (2027-2032) Table 41. Global RGD Peptide Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global RGD Peptide Sales by Region (2021-2026) & (L) Table 43. Global RGD Peptide Sales Market Share by Region (2021-2026) Table 44. Global RGD Peptide Sales by Region (2027-2032) & (L) Table 45. Global RGD Peptide Sales Market Share by Region (2027-2032) Table 46. Global RGD Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global RGD Peptide Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global RGD Peptide Sales Value Share by Region (2021-2026) Table 49. Global RGD Peptide Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global RGD Peptide Sales Value Share by Region (2027-2032) Table 51. Global RGD Peptide Market Average Price (US$/mL) by Region (2021-2026) Table 52. Global RGD Peptide Market Average Price (US$/mL) by Region (2027-2032) Table 53. Global RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Table 54. Global RGD Peptide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global RGD Peptide Sales by Country (2021-2026) & (L) Table 56. Global RGD Peptide Sales Market Share by Country (2021-2026) Table 57. Global RGD Peptide Sales by Country (2027-2032) & (L) Table 58. Global RGD Peptide Sales Market Share by Country (2027-2032) Table 59. Global RGD Peptide Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global RGD Peptide Sales Value Market Share by Country (2021-2026) Table 61. Global RGD Peptide Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global RGD Peptide Sales Value Market Share by Country (2027-2032) Table 63. Wuhan Tanda Biotechnology Company Information Table 64. Wuhan Tanda Biotechnology Business Overview Table 65. Wuhan Tanda Biotechnology RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 66. Wuhan Tanda Biotechnology RGD Peptide Product Portfolio Table 67. Wuhan Tanda Biotechnology Recent Development Table 68. XIAN RUIXI Company Information Table 69. XIAN RUIXI Business Overview Table 70. XIAN RUIXI RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 71. XIAN RUIXI RGD Peptide Product Portfolio Table 72. XIAN RUIXI Recent Development Table 73. QYAOBIO Company Information Table 74. QYAOBIO Business Overview Table 75. QYAOBIO RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 76. QYAOBIO RGD Peptide Product Portfolio Table 77. QYAOBIO Recent Development Table 78. TGpeptide Company Information Table 79. TGpeptide Business Overview Table 80. TGpeptide RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 81. TGpeptide RGD Peptide Product Portfolio Table 82. TGpeptide Recent Development Table 83. Merck KGaA Company Information Table 84. Merck KGaA Business Overview Table 85. Merck KGaA RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 86. Merck KGaA RGD Peptide Product Portfolio Table 87. Merck KGaA Recent Development Table 88. Allpeptide Company Information Table 89. Allpeptide Business Overview Table 90. Allpeptide RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 91. Allpeptide RGD Peptide Product Portfolio Table 92. Allpeptide Recent Development Table 93. TargetMol Chemicals Company Information Table 94. TargetMol Chemicals Business Overview Table 95. TargetMol Chemicals RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 96. TargetMol Chemicals RGD Peptide Product Portfolio Table 97. TargetMol Chemicals Recent Development Table 98. Santa Cruz Animal Health Company Information Table 99. Santa Cruz Animal Health Business Overview Table 100. Santa Cruz Animal Health RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 101. Santa Cruz Animal Health RGD Peptide Product Portfolio Table 102. Santa Cruz Animal Health Recent Development Table 103. PEPTIDE INSTITUTE Company Information Table 104. PEPTIDE INSTITUTE Business Overview Table 105. PEPTIDE INSTITUTE RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 106. PEPTIDE INSTITUTE RGD Peptide Product Portfolio Table 107. PEPTIDE INSTITUTE Recent Development Table 108. Novatein Biosciences Company Information Table 109. Novatein Biosciences Business Overview Table 110. Novatein Biosciences RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 111. Novatein Biosciences RGD Peptide Product Portfolio Table 112. Novatein Biosciences Recent Development Table 113. Enzo Company Information Table 114. Enzo Business Overview Table 115. Enzo RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 116. Enzo RGD Peptide Product Portfolio Table 117. Enzo Recent Development Table 118. Cell Guidance Systems Company Information Table 119. Cell Guidance Systems Business Overview Table 120. Cell Guidance Systems RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 121. Cell Guidance Systems RGD Peptide Product Portfolio Table 122. Cell Guidance Systems Recent Development Table 123. CD Bioparticles Company Information Table 124. CD Bioparticles Business Overview Table 125. CD Bioparticles RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 126. CD Bioparticles RGD Peptide Product Portfolio Table 127. CD Bioparticles Recent Development Table 128. Bio-Techne Company Information Table 129. Bio-Techne Business Overview Table 130. Bio-Techne RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 131. Bio-Techne RGD Peptide Product Portfolio Table 132. Bio-Techne Recent Development Table 133. BICO(Advanced BioMatrix) Company Information Table 134. BICO(Advanced BioMatrix) Business Overview Table 135. BICO(Advanced BioMatrix) RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 136. BICO(Advanced BioMatrix) RGD Peptide Product Portfolio Table 137. BICO(Advanced BioMatrix) Recent Development Table 138. ApexBio Technology Company Information Table 139. ApexBio Technology Business Overview Table 140. ApexBio Technology RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 141. ApexBio Technology RGD Peptide Product Portfolio Table 142. ApexBio Technology Recent Development Table 143. AnaSpec Company Information Table 144. AnaSpec Business Overview Table 145. AnaSpec RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 146. AnaSpec RGD Peptide Product Portfolio Table 147. AnaSpec Recent Development Table 148. Abbiotec Company Information Table 149. Abbiotec Business Overview Table 150. Abbiotec RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 151. Abbiotec RGD Peptide Product Portfolio Table 152. Abbiotec Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. RGD Peptide Distributors List Table 156. RGD Peptide Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. RGD Peptide Product Image Figure 2. Global RGD Peptide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 4. Global RGD Peptide Sales (2021-2032) & (L) Figure 5. Global RGD Peptide Sales Average Price (US$/mL) & (2021-2032) Figure 6. Global RGD Peptide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. RGD Cyclic Peptide Image Figure 10. Linear RGD Peptide Image Figure 11. Global RGD Peptide Sales Volume by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global RGD Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global RGD Peptide Sales Volume Share by Type (2021-2032) Figure 14. Global RGD Peptide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global RGD Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global RGD Peptide Sales Value Share by Type (2021-2032) Figure 17. Pharmaceuticals Image Figure 18. Scientific Research Image Figure 19. Global RGD Peptide Sales Volume by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global RGD Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global RGD Peptide Sales Volume Share by Application (2021-2032) Figure 22. Global RGD Peptide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global RGD Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global RGD Peptide Sales Value Share by Application (2021-2032) Figure 25. Global RGD Peptide Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 26. Global RGD Peptide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global RGD Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global RGD Peptide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 30. North America RGD Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 32. Europe RGD Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific RGD Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 36. South America RGD Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa RGD Peptide Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa RGD Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt RGD Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt RGD Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt RGD Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. RGD Peptide Value Chain Figure 124. Manufacturing Cost Structure Figure 125. RGD Peptide Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • RGD Cyclic Peptide
  • Linear RGD Peptide
Applications
  • Pharmaceuticals
  • Scientific Research
Companies covered
  • Wuhan Tanda Biotechnology
  • XIAN RUIXI
  • QYAOBIO
  • TGpeptide
  • Merck KGaA
  • Allpeptide
  • TargetMol Chemicals
  • Santa Cruz Animal Health
  • PEPTIDE INSTITUTE
  • Novatein Biosciences
  • Enzo
  • Cell Guidance Systems
  • CD Bioparticles
  • Bio-Techne
  • BICO(Advanced BioMatrix)
  • ApexBio Technology
  • AnaSpec
  • Abbiotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global RGD Peptide Sales Value (2021-2032)
  4. 1.2.2 Global RGD Peptide Sales Volume (2021-2032)
  5. 1.2.3 Global RGD Peptide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 RGD Peptide Market Dynamics
  1. 2.1 RGD Peptide Industry Trends
  2. 2.2 RGD Peptide Industry Drivers
  3. 2.3 RGD Peptide Industry Opportunities and Challenges
  4. 2.4 RGD Peptide Industry Restraints
3 RGD Peptide Market by Company
  1. 3.1 Global RGD Peptide Company Revenue Ranking in 2025
  2. 3.2 Global RGD Peptide Revenue by Company (2021-2026)
  3. 3.3 Global RGD Peptide Sales Volume by Company (2021-2026)
  4. 3.4 Global RGD Peptide Average Price by Company (2021-2026)
  5. 3.5 Global RGD Peptide Company Ranking (2024-2026)
  6. 3.6 Global RGD Peptide Company Manufacturing Base and Headquarters
  7. 3.7 Global RGD Peptide Company Product Type and Application
  8. 3.8 Global RGD Peptide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global RGD Peptide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 RGD Peptide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 RGD Peptide Market by Type
  1. 4.1 RGD Peptide Type Introduction
  2. 4.1.1 RGD Cyclic Peptide
  3. 4.1.2 Linear RGD Peptide
  4. 4.2 Global RGD Peptide Sales Volume by Type
  5. 4.2.1 Global RGD Peptide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global RGD Peptide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global RGD Peptide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global RGD Peptide Sales Value by Type
  9. 4.3.1 Global RGD Peptide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global RGD Peptide Sales Value by Type (2021-2032)
  11. 4.3.3 Global RGD Peptide Sales Value Share by Type (2021-2032)
5 RGD Peptide Market by Application
  1. 5.1 RGD Peptide Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Scientific Research
  4. 5.2 Global RGD Peptide Sales Volume by Application
  5. 5.2.1 Global RGD Peptide Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global RGD Peptide Sales Volume by Application (2021-2032)
  7. 5.2.3 Global RGD Peptide Sales Volume Share by Application (2021-2032)
  8. 5.3 Global RGD Peptide Sales Value by Application
  9. 5.3.1 Global RGD Peptide Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global RGD Peptide Sales Value by Application (2021-2032)
  11. 5.3.3 Global RGD Peptide Sales Value Share by Application (2021-2032)
6 RGD Peptide Regional Sales and Value Analysis
  1. 6.1 Global RGD Peptide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global RGD Peptide Sales by Region (2021-2032)
  3. 6.2.1 Global RGD Peptide Sales by Region: 2021-2026
  4. 6.2.2 Global RGD Peptide Sales by Region (2027-2032)
  5. 6.3 Global RGD Peptide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global RGD Peptide Sales Value by Region (2021-2032)
  7. 6.4.1 Global RGD Peptide Sales Value by Region: 2021-2026
  8. 6.4.2 Global RGD Peptide Sales Value by Region (2027-2032)
  9. 6.5 Global RGD Peptide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America RGD Peptide Sales Value (2021-2032)
  12. 6.6.2 North America RGD Peptide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe RGD Peptide Sales Value (2021-2032)
  15. 6.7.2 Europe RGD Peptide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific RGD Peptide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific RGD Peptide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America RGD Peptide Sales Value (2021-2032)
  21. 6.9.2 South America RGD Peptide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa RGD Peptide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa RGD Peptide Sales Value Share by Country, 2025 VS 2032
7 RGD Peptide Country-level Sales and Value Analysis
  1. 7.1 Global RGD Peptide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global RGD Peptide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global RGD Peptide Sales by Country (2021-2032)
  4. 7.3.1 Global RGD Peptide Sales by Country (2021-2026)
  5. 7.3.2 Global RGD Peptide Sales by Country (2027-2032)
  6. 7.4 Global RGD Peptide Sales Value by Country (2021-2032)
  7. 7.4.1 Global RGD Peptide Sales Value by Country (2021-2026)
  8. 7.4.2 Global RGD Peptide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA RGD Peptide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA RGD Peptide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA RGD Peptide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada RGD Peptide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada RGD Peptide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada RGD Peptide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico RGD Peptide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico RGD Peptide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico RGD Peptide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany RGD Peptide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany RGD Peptide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany RGD Peptide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France RGD Peptide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France RGD Peptide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France RGD Peptide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. RGD Peptide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. RGD Peptide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. RGD Peptide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy RGD Peptide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy RGD Peptide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy RGD Peptide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain RGD Peptide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain RGD Peptide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain RGD Peptide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia RGD Peptide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia RGD Peptide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia RGD Peptide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands RGD Peptide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands RGD Peptide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands RGD Peptide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries RGD Peptide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries RGD Peptide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries RGD Peptide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China RGD Peptide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China RGD Peptide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China RGD Peptide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan RGD Peptide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan RGD Peptide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan RGD Peptide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea RGD Peptide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea RGD Peptide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea RGD Peptide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India RGD Peptide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India RGD Peptide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India RGD Peptide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia RGD Peptide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia RGD Peptide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia RGD Peptide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia RGD Peptide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia RGD Peptide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia RGD Peptide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil RGD Peptide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil RGD Peptide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil RGD Peptide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina RGD Peptide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina RGD Peptide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina RGD Peptide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile RGD Peptide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile RGD Peptide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile RGD Peptide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia RGD Peptide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia RGD Peptide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia RGD Peptide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru RGD Peptide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru RGD Peptide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru RGD Peptide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia RGD Peptide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia RGD Peptide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia RGD Peptide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel RGD Peptide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel RGD Peptide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel RGD Peptide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE RGD Peptide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE RGD Peptide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE RGD Peptide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey RGD Peptide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey RGD Peptide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey RGD Peptide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran RGD Peptide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran RGD Peptide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran RGD Peptide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt RGD Peptide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt RGD Peptide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt RGD Peptide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Tanda Biotechnology
  2. 8.1.1 Wuhan Tanda Biotechnology Company Information
  3. 8.1.2 Wuhan Tanda Biotechnology Business Overview
  4. 8.1.3 Wuhan Tanda Biotechnology RGD Peptide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Tanda Biotechnology RGD Peptide Product Portfolio
  6. 8.1.5 Wuhan Tanda Biotechnology Recent Developments
  7. 8.2 XIAN RUIXI
  8. 8.2.1 XIAN RUIXI Company Information
  9. 8.2.2 XIAN RUIXI Business Overview
  10. 8.2.3 XIAN RUIXI RGD Peptide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 XIAN RUIXI RGD Peptide Product Portfolio
  12. 8.2.5 XIAN RUIXI Recent Developments
  13. 8.3 QYAOBIO
  14. 8.3.1 QYAOBIO Company Information
  15. 8.3.2 QYAOBIO Business Overview
  16. 8.3.3 QYAOBIO RGD Peptide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 QYAOBIO RGD Peptide Product Portfolio
  18. 8.3.5 QYAOBIO Recent Developments
  19. 8.4 TGpeptide
  20. 8.4.1 TGpeptide Company Information
  21. 8.4.2 TGpeptide Business Overview
  22. 8.4.3 TGpeptide RGD Peptide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TGpeptide RGD Peptide Product Portfolio
  24. 8.4.5 TGpeptide Recent Developments
  25. 8.5 Merck KGaA
  26. 8.5.1 Merck KGaA Company Information
  27. 8.5.2 Merck KGaA Business Overview
  28. 8.5.3 Merck KGaA RGD Peptide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck KGaA RGD Peptide Product Portfolio
  30. 8.5.5 Merck KGaA Recent Developments
  31. 8.6 Allpeptide
  32. 8.6.1 Allpeptide Company Information
  33. 8.6.2 Allpeptide Business Overview
  34. 8.6.3 Allpeptide RGD Peptide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Allpeptide RGD Peptide Product Portfolio
  36. 8.6.5 Allpeptide Recent Developments
  37. 8.7 TargetMol Chemicals
  38. 8.7.1 TargetMol Chemicals Company Information
  39. 8.7.2 TargetMol Chemicals Business Overview
  40. 8.7.3 TargetMol Chemicals RGD Peptide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 TargetMol Chemicals RGD Peptide Product Portfolio
  42. 8.7.5 TargetMol Chemicals Recent Developments
  43. 8.8 Santa Cruz Animal Health
  44. 8.8.1 Santa Cruz Animal Health Company Information
  45. 8.8.2 Santa Cruz Animal Health Business Overview
  46. 8.8.3 Santa Cruz Animal Health RGD Peptide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Santa Cruz Animal Health RGD Peptide Product Portfolio
  48. 8.8.5 Santa Cruz Animal Health Recent Developments
  49. 8.9 PEPTIDE INSTITUTE
  50. 8.9.1 PEPTIDE INSTITUTE Company Information
  51. 8.9.2 PEPTIDE INSTITUTE Business Overview
  52. 8.9.3 PEPTIDE INSTITUTE RGD Peptide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 PEPTIDE INSTITUTE RGD Peptide Product Portfolio
  54. 8.9.5 PEPTIDE INSTITUTE Recent Developments
  55. 8.10 Novatein Biosciences
  56. 8.10.1 Novatein Biosciences Company Information
  57. 8.10.2 Novatein Biosciences Business Overview
  58. 8.10.3 Novatein Biosciences RGD Peptide Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novatein Biosciences RGD Peptide Product Portfolio
  60. 8.10.5 Novatein Biosciences Recent Developments
  61. 8.11 Enzo
  62. 8.11.1 Enzo Company Information
  63. 8.11.2 Enzo Business Overview
  64. 8.11.3 Enzo RGD Peptide Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Enzo RGD Peptide Product Portfolio
  66. 8.11.5 Enzo Recent Developments
  67. 8.12 Cell Guidance Systems
  68. 8.12.1 Cell Guidance Systems Company Information
  69. 8.12.2 Cell Guidance Systems Business Overview
  70. 8.12.3 Cell Guidance Systems RGD Peptide Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cell Guidance Systems RGD Peptide Product Portfolio
  72. 8.12.5 Cell Guidance Systems Recent Developments
  73. 8.13 CD Bioparticles
  74. 8.13.1 CD Bioparticles Company Information
  75. 8.13.2 CD Bioparticles Business Overview
  76. 8.13.3 CD Bioparticles RGD Peptide Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CD Bioparticles RGD Peptide Product Portfolio
  78. 8.13.5 CD Bioparticles Recent Developments
  79. 8.14 Bio-Techne
  80. 8.14.1 Bio-Techne Company Information
  81. 8.14.2 Bio-Techne Business Overview
  82. 8.14.3 Bio-Techne RGD Peptide Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Techne RGD Peptide Product Portfolio
  84. 8.14.5 Bio-Techne Recent Developments
  85. 8.15 BICO(Advanced BioMatrix)
  86. 8.15.1 BICO(Advanced BioMatrix) Company Information
  87. 8.15.2 BICO(Advanced BioMatrix) Business Overview
  88. 8.15.3 BICO(Advanced BioMatrix) RGD Peptide Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 BICO(Advanced BioMatrix) RGD Peptide Product Portfolio
  90. 8.15.5 BICO(Advanced BioMatrix) Recent Developments
  91. 8.16 ApexBio Technology
  92. 8.16.1 ApexBio Technology Company Information
  93. 8.16.2 ApexBio Technology Business Overview
  94. 8.16.3 ApexBio Technology RGD Peptide Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ApexBio Technology RGD Peptide Product Portfolio
  96. 8.16.5 ApexBio Technology Recent Developments
  97. 8.17 AnaSpec
  98. 8.17.1 AnaSpec Company Information
  99. 8.17.2 AnaSpec Business Overview
  100. 8.17.3 AnaSpec RGD Peptide Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 AnaSpec RGD Peptide Product Portfolio
  102. 8.17.5 AnaSpec Recent Developments
  103. 8.18 Abbiotec
  104. 8.18.1 Abbiotec Company Information
  105. 8.18.2 Abbiotec Business Overview
  106. 8.18.3 Abbiotec RGD Peptide Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Abbiotec RGD Peptide Product Portfolio
  108. 8.18.5 Abbiotec Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 RGD Peptide Value Chain Analysis
  2. 9.1.1 RGD Peptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 RGD Peptide Sales Mode & Process
  6. 9.2 RGD Peptide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 RGD Peptide Distributors
  9. 9.2.3 RGD Peptide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst